AXGN

What one share of Axogen holds

Electromedical and Electrotherapeutic Apparatus

We are the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about providing the opportunity to restore nerve function and quality of life for patients with peripheral nerve injuries.

Axogen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$5.07
Profit−$0.68
Capex (buildings and equipment)$0.13
Free cash flow$0.17
Cash and investments$1.76
Debt$0.00
Book value$4.78

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2010$3.59−$8.35———−$22.49
2011$1.31−$2.77$0.01−$1.92——
2012$0.69−$0.85$0.00−$0.79—−$0.25
2013$0.81−$1.08$0.01−$0.79—$0.01
2014$0.95−$1.00$0.03−$0.62—−$0.58
2015$1.05−$0.51$0.02−$0.52—$0.27
2016$1.34−$0.47$0.03−$0.40—$0.45
2017$1.81−$0.31$0.03−$0.31—$0.73
2018$2.26−$0.60$0.17−$0.65—$3.78
2019$2.72−$0.74$0.12−$0.63—$3.34
2020$2.81−$0.60$0.55−$0.79—$3.03
2021$3.09−$0.65$0.67−$1.00—$2.70
2022$3.29−$0.69$0.48−$0.86—$2.38
2023$3.71−$0.51$0.32−$0.46—$2.22
2024$4.23−$0.23$0.07$0.03—$2.35
2025$4.89−$0.34$0.08−$0.06—$2.73

Common questions about Axogen

How much does one share of Axogen earn?

Over the last 12 months, Axogen lost $0.68 for each share on $5.07 of sales.

Does Axogen pay a dividend?

Axogen didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Axogen’s book value per share?

Axogen’s book value is $4.78 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Axogen have?

Each share of Axogen has $1.76 of cash and investments and $0.00 of debt, as of June 30, 2026.

What is Axogen’s free cash flow per share?

$0.17 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Axogen bought back shares?

Axogen’s share count rose about 5401% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.